For subscribers
News analysis
Why Europe seeks to reduce its dependency on China for pharmaceutical products
Sign up now: Get ST's newsletters delivered to your inbox
European governments said that up to 40 per cent of the pharmaceutical ingredients used worldwide are manufactured in China.
PHOTO: ST FILE
Follow topic:
LONDON – The European Union is being urged to adopt urgent measures to reduce the bloc’s dependency on imports of pharmaceutical ingredients from China, thereby shoring up Europe’s medical supply resilience and avoiding future drug shortages.
In a confidential policy paper leaked to the media, 19 out of the EU’s current 27 member-states are asking the European Commission, the Union’s executive body, to adopt a so-called Critical Medicines Act that would encourage the production of crucial medicine on the continent, similar to the way the Commission is now pushing towards Europe’s self-reliance in microchips.
